Europe Leukapheresis Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Leukapheresis Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Leukapheresis Market Regional Analysis

6.2 Europe Leukapheresis Market Revenue 2019-2028 (US$ Million)

6.3 Europe Leukapheresis Market Forecast Analysis

7. Europe Leukapheresis Market Analysis – by Product Type

7.1 Leukapheresis Devices

7.1.1 Overview
7.1.2 Leukapheresis Devices: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Leukapheresis Disposables

7.2.1 Overview
7.2.2 Leukapheresis Disposables: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Leukapheresis Market Analysis – by Application

8.1 Research Applications

8.1.1 Overview
8.1.2 Research Applications: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Therapeutic Applications

8.2.1 Overview
8.2.2 Therapeutic Applications: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Leukapheresis Market Analysis – by End User

9.1 Blood Component Providers and Blood Centers

9.1.1 Overview
9.1.2 Blood Component Providers and Blood Centers: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Academic and Research Institutes

9.2.1 Overview
9.2.2 Academic and Research Institutes: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Hospitals and Transfusion Centers

9.4.1 Overview
9.4.2 Hospitals and Transfusion Centers : Europe Leukapheresis Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Leukapheresis Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Leukapheresis Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Leukapheresis Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.1.2 UK: Europe Leukapheresis Market Breakdown, by Application
10.2.1.1.3 UK: Europe Leukapheresis Market Breakdown, by End User

10.2.1.2 Germany: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.2.2 Germany: Europe Leukapheresis Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Leukapheresis Market Breakdown, by End User

10.2.1.3 France: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.3.2 France: Europe Leukapheresis Market Breakdown, by Application
10.2.1.3.3 France: Europe Leukapheresis Market Breakdown, by End User

10.2.1.4 Russia: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.4.2 Russia: Europe Leukapheresis Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Leukapheresis Market Breakdown, by End User

10.2.1.5 Italy: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.5.2 Italy: Europe Leukapheresis Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Leukapheresis Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Leukapheresis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Leukapheresis Market Breakdown, by Product Type
10.2.1.6.2 Rest of Europe: Europe Leukapheresis Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Leukapheresis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Leukapheresis Market